| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS INC | Director | Common Stock | 132,141 | $532,528 | $4.03 | 05 Jun 2025 | Direct |
| Coherus Oncology, Inc. | Director | Stock Option (Right to Buy) | 112,000 | 12 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CHRS | Coherus Oncology, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 18:50 |
| MYGN | MYRIAD GENETICS INC | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:04 |
| MYGN | MYRIAD GENETICS INC | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:54 |
| CHRS | Coherus BioSciences, Inc. | 03 Jun 2024 | 1 | $0 | 4 | Director | 05 Jun 2024, 18:47 |
| MYGN | MYRIAD GENETICS INC | 13 May 2024 | 1 | -$156,860 | 4 | Director | 15 May 2024, 17:48 |
| CHRS | Coherus BioSciences, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 17:07 |
| MYGN | MYRIAD GENETICS INC | 01 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 18:07 |
| MYGN | MYRIAD GENETICS INC | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 17:26 |
| CHRS | Coherus BioSciences, Inc. | 02 Feb 2022 | 1 | $0 | 4 | Director | 04 Feb 2022, 19:19 |
| CHRS | Coherus BioSciences, Inc. | 02 Feb 2022 | 0 | $0 | 3 | Director | 04 Feb 2022, 19:19 |
| MYGN | MYRIAD GENETICS INC | 03 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 19:02 |